Cerebral
Telehealth ADHD prescribing at scale attracted DEA scrutiny and a DOJ investigation for potential controlled substance fraud.
Cerebral was a Healthcare/Telehealth startup founded in 2020 in USA. It raised $300M before collapsing in 2024 — 4 years of runway burned. IdeaProof's AI Failure Score: 82/100, driven by overprescription scandal & doj investigation. The shutdown affected employees, investors, and the broader Healthcare/Telehealth ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.
Why did Cerebral fail?
Cerebral failed in 2024 after 4 years of operation, losing $300M in raised capital. The root cause was overprescription scandal & doj investigation. Key lesson: Telehealth ADHD prescribing at scale attracted DEA scrutiny and a DOJ investigation for potential controlled substance fraud.
2020 → 2024
$300M
Healthcare/Telehealth
USA
IdeaProof AI Failure Score
What Happened: The Timeline
2020
Cerebral founded for online mental health treatment
2022
Reaches $4.8B valuation, 4,500 employees
2022
Reports of over-prescribing stimulants, DEA investigation
2024
Founder charged with fraud, massive downsizing
Root Causes
Cerebral was a telehealth startup specializing in mental health, particularly ADHD and anxiety. The company grew explosively during COVID, reaching a $4.8B valuation. But reports emerged that Cerebral was aggressively prescribing controlled substances (Adderall, Xanax) with minimal evaluation. The DEA and DOJ launched investigations. CVS and Walmart stopped filling Cerebral prescriptions. The company downsized dramatically and founder Kyle Robertson was charged with fraud in 2024.
Sources & References
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Cerebral.